Rank | Title | Journal | Year | PubWeight™‹?› |
---|---|---|---|---|
1 | Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis. | Nat Neurosci | 2002 | 3.66 |
2 | Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine. | Nat Med | 2002 | 2.31 |
3 | Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient. | Clin Infect Dis | 2006 | 0.94 |
4 | Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications. | Neurochem Int | 2002 | 0.85 |
5 | Persistent choreoathetosis in a fatal olanzapine overdose: drug kinetics, neuroimaging, and neuropathology. | Am J Psychiatry | 2005 | 0.83 |
6 | Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy. | Neurobiol Dis | 2011 | 0.78 |
7 | July 2001: 58-year-old man with a temporal bone mass. | Brain Pathol | 2002 | 0.75 |